Investment Trusts
Baillie Gifford US Growth Trust invests for long-term capital growth in innovative US companies, including both listed and privately owned businesses. The portfolio is concentrated in companies the managers believe can grow substantially over many years.
Investment in quoted US growth companies, private-company investments, participation in funding rounds, active portfolio management and share buybacks.
The United States, particularly technology, consumer internet, software, biotechnology and other innovation-led sectors.
Growth and valuations of major holdings, successful private-company funding and exits, US equity-market sentiment, interest rates, technology adoption and the trust's discount to NAV.
High growth-stock volatility, concentrated holdings, private-company valuation uncertainty, technology disruption, rising interest rates and a persistent discount to NAV.
At the end of June 2026 the trust's NAV was 333.55p per share versus a 306p share price, representing an 8.3% discount, with modest net gearing of about 3%. The May year-end results and September AGM provide an opportunity to assess private-company valuations, portfolio concentration and whether the discount can narrow into 2027.
The trust is managed entirely for capital growth and does not currently pay a dividend. Its June 2026 factsheet recorded a dividend yield of nil, with shareholder returns dependent on NAV growth, successful private investments and discount management.
The complete 350 Trade Book — 350 leading UK-listed companies, presented in one consistent working reference.